Skip to main content
Category

Uncategorized

ARRIGE in French: interview to Sylvain Moineau and Christian Siatka on CRISPR basics

By CRISPR, In French, meeting, Uncategorized, videoNo Comments

The last (November 2017) annual meeting of the SFG (Société Française de Génétique / French Genetics Society) in Montpellier (France)  was devoted to CRISPR : The CRISPR revolution: from bacterial immunity to functional genomics. The meeting organizers (among which one of the members of the ARRIGE Steering Committee, Cyril Sarrauste de Menthière) made an interview (in French) to Sylvain Moineau (Université Laval, Québec, Canada; one of the pioneers of the CRISPR systems in bacteria) and Christian Siatka (Director of the “Ecole de l’ADN”). This video, now available from the YouTube platform is here enclosed, within the ARRIGE blog, for educational purposes

Francis Mojica delivered a keynote lecture on the origins of CRISPR systems and their applications at the recent ARRIGE kick-off meeting in Paris

By arrige, CRISPR, meeting, UncategorizedNo Comments
Francis Mojica, microbiologist from the University of Alicante (Spain) who discovered the CRISPR arrays in archaea, coined the name of CRISPR and first proposed that this was a prokaryote acquired immune defense system.

The recent ARRIGE kick-off meeting in Paris had the pleasure to have Francisco Juan Martínez Mojica (Francis Mojica), microbiologist from the University of Alicante (Spain), delivering the first keynote lecture of the conference. In his very interesting talk, Francis Mojica reviewed the origins of the CRISPR systems in prokaryotes, as part of an ancient acquired immune defense system, and their recent conversion into powerful genome editing tools. He is convinced that we are just beginning to understand the unexpected complexity of bacterial immune systems. CRISPR could be just one of many, yet to be identified and described. There is a great future ahead in the field of Molecular Microbiology for discovering new CRISPR and CRISPR-like systems that could be transformed and adapted for the efficient and safe manipulation of genomes, including the human genome.